[1] Selmi C,Bowlus CL.Gershwin ME,et al.Primary biliary cirrhosis.Lancet,2011,377:1600-1609.
[2] Carbo A, Hontecillas R,Andrew T,et al.Computational modeling of heterogeneity and function of CD4+T cells .Front Cell Dev Biol,2014,2:31.
[3] Webb GJ,Siminovitch KA,Hirschfield GM.The immunogenetics of primary biliary cirrhosis:a comprehensive review.Journal of Autoimmunity,2015,64:42-52.
[4] Heroid M,Posevitz V,Chudyka D,et al.B7-H1 selective controls TH17 differentiation and central nervous system autoimmunity via a novel non-PD-1 mediated pathway.Journal of Immunology,2015,195:3584-3595.
[5] Carbone M,Neuberger JM.Autoimmune liver disease,autoimm-unity and liver transplantation J J. Journal of hepatology,2014,60:210-223.
[6] Liu H. Prevalence of primary hiliary cirrhosis in adults referring hospital for annual health check-up in southern China .BMC Gastroenterol,2010,10:100.
[7] Lafdil F,Miller AM,Ki SH,et al. Th17 cells and their ass-ociated cytokines in liver diseases. Cell Mol Immunol,2010,7:250-254.
[8] Kawata K,Tsuda M,Yang GX,et al. Identification of potential cytokine pathways for therapeutic intervention in murine prim-ary biliary cirrhosis . PLos One,2013,8:e74225.
[9] Yang CY,Ma X,Tsuneyama K,et al. IL-12/ Th1 andIL-23/ Th17 biliary microenvironment in primary biliary cirrhosis:implications for therapy . Hepatology,2014,59:1944-1953.
[10] Irschfield GM,Gershwinme.The immunobiology and pathophy-sioIogy of primary biliary cirrhosis.Annu Rev Pathol,2013,8:303-330. |
